]>
IRCT20190912044755N1 IRCT 2019-10-10 Mazandaran University of Medical Sciences Survey of the effect of Gingko Biloba on cataract Determination of the effect of Gingko Biloba​ extract on redox state of human serum and aqueous albumin in patients with senile cataract 2015-02-19 anticipated 146 Complete https://irct.ir/trial/42163 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Randomization on an individual level using 4 number blocks created in excel software. Allocation concealment has been carried out, Blinding description: A placebo identical to the GbE capsules was provided to the patients, so neither the patient nor the physician were aware of the supplementation. Patients and their data were coded and documented using codes and data analysis was carried out using these codes. 3 Senile cataract. Intervention 1: Intervention group: GBE,capsule 200 mg po,daily for 16weeks. Intervention 2: Control group: placebo,capsule 200 mg po,daily for 16weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information
public Ahmad Ahmadzadeh Amiri
Pasdaran Blvd
Sari Iran (Islamic Republic of) 4815838477 +98 11 3332 5734 ahmadzdh@yahoo.com Mazandaran University of Medical Sciences scientific Ahmad Ahmadzadeh Amiri
Pasdaran Blvd
Sari Iran (Islamic Republic of) 4815838477 +98 11 3332 5734 ahmadzdh@yahoo.com Mazandaran University of Medical Sciences Iran (Islamic Republic of) Senile cataract 50 years 85 years Both History of cardiac diseases History of renal diseases History of neurological diseases History of Diabetes Mellitus History of rheumatologic diseases History of hematologic diseases History of thyroid diseases Receiving of estrogen-steroid, immunosuppressive and anticoagulant-anti platelet agents History of ophthalmic diseases and surgery H25 Age-related cataract Prevention Placebo Intervention group: GBE,capsule 200 mg po,daily for 16weeks Control group: placebo,capsule 200 mg po,daily for 16weeks Posterior Capsule Opacification. Timepoint: 6, 12, 36 weeks after cataract surgery. Method of measurement: Slit-lamp bio microscopic examination of eyes. Mazandaran University of Medical Sciences Approved 2011-12-21 Ethics committee of Mazandaran University of Medical Sciences 17th km Khazarabad Blv Sari Mazandaran Iran (Islamic Republic of)